ORBi: Detailled Reference

Article (Scientific journals)

Activite antalgique de la glucosamine dans l'arthrose: quoi de neuf en 2006?

Reginster, Jean-Yves; Richy, F.; Bruyère, Olivier

2006 • In Revue Médicale de Liège, 61 (3), p. 169-72

Peer reviewed

Permalink
https://hdl.handle.net/2268/20033

PubMed
16681003

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

ACTIVITÉ ANTALGIQUE DE LA GLUCOSAMINE.pdf

Publisher postprint (447.98 kB)

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Abstract :

[en] Glucosamine is widely used as a symptom-modifying drug in osteoarthritis. New clinical trials, from Europe and the United-States bring some clarification regarding the optimal formulation and doses to be used in knee osteoarthritis. Their results are supported by new pharmacokinetic and preclinical studies, explaining the mode of action of glucosamine in osteoarthritis.

Disciplines :

Rheumatology

Author, co-author :

Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie et santé publique

Richy, F.

Bruyère, Olivier ; Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie et santé publique

Language :

French

Title :

Activite antalgique de la glucosamine dans l'arthrose: quoi de neuf en 2006?

Alternative titles :

[en] Glucosamine as a Pain-Modifying Drug in Osteorthritis. What's New in 2006

Publication date :

March 2006

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

61

Issue :

3

Pages :

169-72

Peer reviewed :

Peer reviewed

Available on ORBi :

since 27 August 2009

Statistics

Number of views

245 (2 by ULiège)

Number of downloads

470 (2 by ULiège)

More statistics

Scopus citations^®

5

Scopus citations^®
without self-citations

5

OpenAlex citations

1

Bibliography

Reginster JY, Deroisy R, Rovati LC, et al.- Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet. 2001, 357, 251-256.
Pavelka K, Gatterova J, Olejarova M, et al.- Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med, 2002, 162, 2113-2223.
Herrero-Beaumont G, Roman JA, Trabado MC, et al.- Effects of glucosamine sulfate on 6-month control of knee osteoarthritis symptoms vs placebo and acetaminophen: results from the Glucosamine. Unum in Die Efficacy (GUIDE) trial. (abstract) Arthritis Rheum, 2005, 52, 460.
Clegg DO, Reda DJ, Harris CL, et al.- Glucosamine, chondroitine sulphate, and the two in combination for painful knee osteoarthritis. N Engl J Med, 2006, 354, 795-808.
Hochberg MC.- Nutritional supplements for knee osteoarthritis-still no resolution. N Engl J Med, 2006, 354, 858-860.
Jordan KM, Arden NK, Doherty M, et al.- Standing Committee for International Clinical Studies Including Therapeutic Trials ESCISIT. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003, 62, 1145-1155.
Russell AS, Aghazadeh-Habashi A, Jamali F.- Active ingredient consistency of commercially available glucosamine sulfate products. J Rheumatol, 2002, 29, 2407-2409.
Hoffer LJ, Kaplan LN, Hamadeh MJ, et al.- Sulfate could mediate the therapeutic effect of glucosamine sulfate. Metabolism, 2001, 50, 767-770.
Cordobal F, Nimni ME.- Chondroitin sulfate and other sulfate containing chondroprotective agents may exhibit their effects by overcoming a deficiency of sulphur amino acids. Osteoathritis Cartilage, 2003, 11, 228-230.
Towheed TE, Maxwell L, Anastassiades TP, et al.- Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev, 2005, 2, CD002946.
Mroz PJ, Silbert JE.- Use of 3 H-glucosamine and 35 S-sulfate with cultured human chondrocytes to determine the effect of glucosamine concentration on formation of chondroitin sulfate. Arthritis Rheum, 2004, 50, 3574-3579.
Largo R, Alvarez-Soria MA, Diez-Ortego I, et al.- Glucosamine inhibits IL-1β-induced NFkB activation in human osteoarthritis chondrocytes. Osteoarthritis Cartilage, 2003, 11, 290-298.
Piepoli T, Zanelli T, Letari O, et al.- Glucosamine sulphate inhibits IL-1-stimulated gene expression at concentrations found in human plasma after oral intake. Osteoarthritis Cartilage, 2005, 13, 304.
Persiani S, Rotini R, Trisolino G, et al.- Glucosamine plasma and synovial fluid concentrations before and after oral administration of crystalline glucosamine sulfate in knee osteoarthritis patients. Arthritis Rheum, 2005, 9, 1342.

Similar publications